Human immunodeficiency virus type 1 Vif protein binds to the Pr55(Gag) precursor

被引:91
作者
Bouyac, M
Courcoul, M
Bertola, G
Baudat, Y
Gabuzda, D
Blanc, D
Chazal, N
Boulanger, P
Sire, J
Vigne, R
Spire, B
机构
[1] INSERM,U372,F-13276 MARSEILLE 09,FRANCE
[2] FAC MED MONTPELLIER,INST BIOL,CNRS URA 1487,VIRAL & MOL PATHOGENESIS LAB,MONTPELLIER,FRANCE
[3] DANA FARBER CANC INST,DIV HUMAN RETROVIROL,BOSTON,MA 02115
关键词
D O I
10.1128/JVI.71.12.9358-9365.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Vif protein of human immunodeficiency virus type 1 is required for productive replication in peripheral blood lymphocytes. Previous reports suggest that vif-deleted viruses are limited in replication because of a defect in the late steps of the virus life cycle. One of the remaining questions is to determine whether the functional role of Vif involves a specific interaction with virus core proteins. In this study, we demonstrate a direct interaction between Vif and the pr55(Gag) precursor in vitro as well as in infected cells. No interaction is observed between Vif and the mature capsid protein. The pr55(Gag)-Vif interaction is detected (i) in the glutathione S-transferase system, with in vitro-translated proteins demonstrating a critical role of the NC p7 domain of the Gag precursor; (ii) with proteins expressed in infected cells; and (iii) by coimmunoprecipitation experiments. Deletion of the C-terminal 22 amino acids of Vif abolishes its interaction with the Pr55(Gag) precursor. Furthermore, point mutations in the C-terminal domain of Vif which have been previously shown to abolish virus infectivity and binding to cell membranes dramatically decrease the Gag-Vif interaction. These results suggest that the interaction between Vif and the Pr55(Gag) precursor is a critical determinant of Vif function.
引用
收藏
页码:9358 / 9365
页数:8
相关论文
共 49 条
  • [1] PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE
    ADACHI, A
    GENDELMAN, HE
    KOENIG, S
    FOLKS, T
    WILLEY, R
    RABSON, A
    MARTIN, MA
    [J]. JOURNAL OF VIROLOGY, 1986, 59 (02) : 284 - 291
  • [2] The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB
    Agostini, I
    Navarro, JM
    Rey, F
    Bouhamdan, M
    Spire, B
    Vigne, R
    Sire, J
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1996, 261 (05) : 599 - 606
  • [3] BENICHOU S, 1994, J BIOL CHEM, V269, P30073
  • [4] TRANSCOMPLEMENTATION OF VIF- HIV-1 MUTANTS IN CEM CELLS SUGGESTS THAT VIF AFFECTS LATE STEPS OF THE VIRAL LIFE-CYCLE
    BLANC, D
    PATIENCE, C
    SCHULZ, TF
    WEISS, R
    SPIRE, B
    [J]. VIROLOGY, 1993, 193 (01) : 186 - 192
  • [5] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY
    BORMAN, AM
    QUILLENT, C
    CHARNEAU, P
    DAUGUET, C
    CLAVEL, F
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2058 - 2067
  • [6] Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme
    Bouhamdan, M
    Benichou, S
    Rey, F
    Navarro, JM
    Agostini, I
    Spire, B
    Camonis, J
    Slupphaug, G
    Vigne, R
    Benarous, R
    Sire, J
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 697 - 704
  • [7] Phenotypically Vif(-) human immunodeficiency virus type 1 is produced by chronically infected restrictive cells
    Bouyac, M
    Rey, F
    Nascimbeni, M
    Courcoul, M
    Sire, J
    Blanc, D
    Clavel, F
    Vigne, R
    Spire, B
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (03) : 2473 - 2477
  • [8] Characterization of human immunodeficiency virus type 1 Vif particle incorporation
    Camaur, D
    Trono, D
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (09) : 6106 - 6111
  • [9] CARRIERE C, 1995, J VIROL, V69, P2366
  • [10] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MA DELETION MUTANTS EXPRESSED IN BACULOVIRUS-INFECTED CELLS - CIS AND TRANS EFFECTS ON THE GAG PRECURSOR ASSEMBLY PATHWAY
    CHAZAL, N
    GAY, B
    CARRIERE, C
    TOURNIER, J
    BOULANGER, P
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (01) : 365 - 375